Title: Evaluation of 3-carboxy-4(1H)-quinolones as inhibitors of human protein kinase CK2.
Journal: Journal of medicinal chemistry 20061102
28027-16-9
26893-22-1
1698-96-0
303121-10-0
5278-40-0
40400-85-9
1094661-15-0 | 1-[(2-tert-butyl-1,3-thiazol-4-yl)methyl]piperazine | AA019MWB | MFCD12068349
34333-31-8 | 2,2,4-Trimethyl-1,2-dihydroquinoline hydrochloride | AA019N18 | MFCD02676172
1172324-93-4 | (2-hydroxy-3-methoxypropyl)(methyl)amine, oxalic acid | AA019N5I | MFCD11505496
1016746-08-9 | 2-{[(4-bromophenyl)methyl]sulfanyl}pyridine-3-carboxylic acid | AA019NAI | MFCD09813157
346613-02-3 | ethyl 2-cyano-3-[(4-ethylphenyl)amino]prop-2-enoate | AA019NFQ | MFCD08771806
289476-22-8 | (1-phenylethyl)(pyridin-4-ylmethyl)amine | AA019NRD | MFCD01475086
852399-57-6 | 3-(4-Methyl-2-oxo-1,3-thiazol-3(2h)-yl)propanoic acid | AA019O29 | MFCD06655502
847781-96-8 | (([1-(5-Bromothien-2-yl)ethylidene]amino)oxy)acetic acid | AA019OA2 | MFCD19596077
863669-55-0 | 1-(Ethylsulfonyl)-4-phenylpiperidine-4-carboxylic acid | AA019OH6 | MFCD07339173
116401-53-7 | 2-fluoro-4-isothiocyanato-1-methylbenzene | AA019OO3 | MFCD00046799